世界中の信頼できる情報源からの Sick に関する最新ニュースとアップデート。
The U.S. Food and Drug Administration has granted accelerated approval to the first CRISPR-based treatment for adults with severe sickle cell disease, a milestone for gene-editing medicine. The…
The U.S. Food and Drug Administration has approved the first gene-editing treatment for adults with severe sickle cell disease, a milestone that could change care for patients with limited options.…
A new gene-editing treatment has shown encouraging early results for people living with severe sickle cell disease, according to interim findings published in The New England Journal of Medicine.…
A first-in-human study of a next-generation CRISPR gene-editing therapy for sickle cell disease has reported encouraging early results. In the phase 1/2 trial, researchers said 80% of the first 25…
Interim data from an early-stage clinical trial suggest a CRISPR-based gene-editing treatment may offer meaningful relief for people living with severe sickle cell disease. Researchers said 92% of…
Researchers have reported encouraging early results from a Phase 1/2 clinical trial of a new CRISPR-based gene-editing therapy for sickle cell disease, offering fresh hope for patients living with…
The U.S. Food and Drug Administration has approved a landmark gene therapy for sickle cell disease, marking a major advance in the treatment of a painful inherited blood disorder that affects…
